Related Experiment Videos
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy
Francisco Ruiz-Cabello1, Teresa Cabrera, Miguel-Angel Lopez-Nevot
1Servicio de Análisis Clínicos, Hospital Universitario Virgen de las Nieves, Granada, Spain. fgarrido@hvn.sas.cica.es
Seminars in Cancer Biology
|April 3, 2002
Summary
Tumor cells can evade immune responses through various mechanisms, impacting cancer therapy. Comprehensive tumor tissue analysis is crucial for patient selection in T cell-based immunotherapy.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Tumor-associated antigens offer novel cancer therapy avenues.
- Tumor cells possess multiple escape mechanisms against immune responses.
- Tumor progression involves antigen heterogeneity, HLA expression changes, and immunosuppression.
Purpose of the Study:
- To highlight the implications of altered HLA class I phenotypes in tumor development.
- To emphasize the necessity of thorough tumor tissue evaluation for immunotherapy suitability.
Main Methods:
- Analysis of tumor cell progression.
- Assessment of HLA expression modulation.
- Evaluation of immune suppressive mechanisms.
Main Results:
- Tumor antigen heterogeneity, altered HLA expression, and immunosuppression are key to immune evasion.
- Changes in HLA class I phenotypes during tumor development have significant biological and medical consequences.
- These alterations impact T cell and Natural Killer (NK) cell functions.
Conclusions:
- Thorough tumor tissue examination is essential before enrolling patients in T cell-based immunotherapy.
- Understanding immune evasion mechanisms is critical for effective cancer treatment strategies.